THURSDAY 12 NOVEMBER 2020
8:30 AM EST (GMT -4)
Coming to you live, from wherever you are
Already registered?
Login & Access Content NowNot yet registered?
Get your pass
Evident with every viral pandemic including COVID-19, rapid deployment of compatible antiviral therapies is of paramount importance, particularly before a long-term strategy of a vaccine is possible.
Antivirals can prevent or control viral diseases from emerging diseases, respiratory infections, chronic diseases to virus-associated tumours.
Join us on this virtual congress to get up to speed and help accelerate your antiviral research from bench to patient.
For event updates, discounts and latest news sign up now.
Exclusive
Interviews
World Leading
Presentations
Interactive
Roundtables
Live Panel
Debates
Virtual Face-to-Face Meetings
Webinars
All Year Round
"The third breakthrough will be in antiviral drugs. These have been an underinvested branch of science. We haven’t been as effective at developing drugs to fight viruses as we have those to fight bacteria. But that will change. Researchers will develop large, diverse libraries of antivirals, which they’ll be able to scan through and quickly find effective treatments for novel viruses."
Bill Gates, writing in The Economist, April 23 2020